Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attitudinal Profiles Toward Medical Mediation Among Healthcare Professionals: Evidence from a Scenario-Based Survey and Latent Class Analysis.

Healthcare (Basel, Switzerland)·2026
Same author

Harnessing Medical Bioethics Mediation to Advance One Health Governance.

Veterinary sciences·2026
Same author

Applications of Medical Mediation: A Systematic Review of Its Role in Healthcare Dispute Resolution and Bioethical Decision-Making.

Healthcare (Basel, Switzerland)·2025
Same author

One Health in Coastal and Marine Contexts: A Critical Bibliometric Analysis Across Environmental, Animal, and Human Health Dimensions.

International journal of environmental research and public health·2025
Same author

Can Improved Biosecurity Measures Reduce the Presence of the Most Common ESBL-Producing <i>Enterobacteriaceae</i>? A Study from Greek Pig Farms.

Life (Basel, Switzerland)·2025
Same author

Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis.

Journal of hepatology·2025

Related Experiment Video

Updated: May 21, 2026

Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

Sex differences associated with primary biliary cirrhosis.

Daniel S Smyk1, Eirini I Rigopoulou, Albert Pares

  • 1Institute of Liver Studies, King's College London School of Medicine, Denmark Hill Campus, London SE59PJ, UK.

Clinical & Developmental Immunology
|June 14, 2012
PubMed
Summary

Primary biliary cirrhosis (PBC) predominantly affects females. This review analyzes the literature on male PBC, exploring potential reasons for its low incidence and differing clinical presentations.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Related Experiment Videos

Last Updated: May 21, 2026

Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Primary biliary cirrhosis (PBC) is an autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts.
  • Antimitochondrial antibodies (AMA) are pathognomonic for PBC diagnosis.
  • PBC predominantly affects females, with males representing only 7-11% of cases.

Purpose of the Study:

  • To critically analyze the existing literature on primary biliary cirrhosis in males.
  • To explore potential reasons for the lower incidence of PBC in males.
  • To examine differences in symptomatology and clinical outcomes between male and female PBC patients.

Main Methods:

  • Literature review and critical analysis of published studies on male PBC.
  • Examination of epidemiological data regarding PBC incidence in males versus females.
  • Review of research investigating potential sex-based differences, including X chromosome and sex hormone studies.

Main Results:

  • While histological, serological, and biochemical profiles are similar, male PBC patients may exhibit a higher risk of severe complications like gastrointestinal bleeding and hepatoma.
  • The underlying reasons for the low incidence of PBC in males remain largely unknown.
  • Studies on sex hormones and the X chromosome have not yet provided conclusive explanations.

Conclusions:

  • Further research is needed to elucidate the factors contributing to the sex disparity in PBC.
  • Understanding these differences is crucial for potentially improving diagnosis and management in male PBC patients.
  • Investigating sex-based biological and hormonal factors may offer insights into PBC pathogenesis.